Bioabsorbable Stents Market Size, Share, Growth, and Industry Analysis, By Type (Peripheral Bioabsorbable Stents, Coronary Bioabsorbable Stents), By Application (The Treatment of Peripheral Blood Vessels Damaged, The Treatment of Peripheral Blood Vessels Blockage), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

BIOABSORBABLE STENTS MARKET OVERVIEW

The global bioabsorbable stents market size was USD 2.2 billion in 2026 and is projected to reach USD 17.7 billion in 2035, exhibiting a CAGR of 25.8% during the forecast period.

Bioresorbable scaffolds, a category of modern medical gadgets, are essentially Bioabsorbable Stents designed for transient use in arteries, often the coronary arteries, to keep them open after blockages. Unlike traditional, everlasting steel stents, those scaffolds are made from biocompatible substances like Poly-l-lactic acid (PLLA) polymer or magnesium-based alloys. Their unique function is the ability to dissolve completely and be harmlessly absorbed by means of the body over a period of 1 to three years, doing away with the need for an everlasting implant. Such a leave-nothing-behind strategy is meant to reinstate the natural functionality and compliance of the blood vessel once the healing process is finished, and may lower the risks of permanent implants having long-term effects in terms of delayed thrombosis of stents or chronic inflammation.

The Bioabsorbable Stents Market has witnessed a tremendous rise in all parts of the world owing to the rising cases of cardiovascular diseases, an ageing population, and the use of minimally invasive procedures. Historically, North America and Europe record a high Bioabsorbable Stents Market Share owing to an established healthcare infrastructure and high procedure volume, but the Asia-Pacific region is expected to make the highest growth rate. Market size is estimated to be hundreds of millions of US dollars and is expected to increase at a healthy Compound Annual Growth Rate (CAGR). The current supersaturation of the world with the use of coronary artery disease applications continues, although there is a progressive increase in the use of peripheral artery disease treatments, with the constant development of biomaterial technology that is resolving the initial safety issues of the first generation.

COVID-19 IMPACT 

The Bioabsorbable Stents Industry Had a Negative Effect Due to Factory Closures During the COVID-19 Pandemic.

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic was an initial shock to the Bioabsorbable Stents Market, as it was the major cause of the drastic drop in elective and non-emergency cardiac and peripheral surgeries in 2020. With the world—in healthcare systems and hospitals alike—reallocating resources, by way of staff, ICU beds, ventilator capacity, among others, to accommodate the excess of COVID-19-afflicted patients, many non-urgent surgeries, such as most coronary stents, were postponed or canceled. This very decrease in the volume of procedures instantly stifled the demand side of the market. Moreover, the pandemic caused a break in the global supply chains and a temporary halt to some of the most important clinical trials and research, and development of next-generation Bioabsorbable Stents. Nevertheless, the market was resilient and started recovering since 2021 due to the ultimate resumption of misplaced procedures, growing global recognition of the high-risk status of cardiovascular comorbidities in COVID-19 patients, and the pre-disposed increasing tendencies in cardiovascular diseases prevalence.

LATEST TRENDS

Focus on Thinner Struts and Faster Resorption to Drive Market Growth

The most recent tendency in the market of Bioabsorbable Stents revolves around the further dramatic improvement of the scaffold design in order to improve performance and elevate the safety of the product. Manufacturers are pursuing next-generation devices with smaller struts to minimize flow perturbation to limit the occurrence of severe complications such as late stent thrombosis. At the same time, one of the most critical changes will be the trend toward more rapid resorption profiles, preferably, the device dissolving completely in 12 to 18 months, contributing to the provision of the natural vaso-motility of the artery at a much earlier time. This dual emphasis on slimmer designs and faster degradation is the solution to the clinical performance issue of the early-generation Bioabsorbable Stents and increases their acceptance throughout the world.

BIOABSORBABLE STENTS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Peripheral Bioabsorbable Stents, Coronary Bioabsorbable Stents.

• Coronary Bioabsorbable Stents: These stents form the greatest market size of the market based on the massive prevalence of coronary artery disease throughout the world, as well as the huge existing pool of procedures of percutaneous coronary intervention (PCI).

• Peripheral Bioabsorbable Stents: This market is the most rapidly expanding application that is being driven by increasing cases of peripheral artery disease (PAD) and new regulatory approvals to be used in more difficult vascular beds, such as below-the-knee arteries.

By Application

Based on the Application, the global market can be categorized into The Treatment of damaged Peripheral Blood Vessels Damaged, The Treatment of Peripheral Blood Vessels Blockage.

• The Treatment of Peripheral Blood Vessels Blockage: The application used in this application includes the use of Bioabsorbable Stents as temporary scaffolding to restore blood flow by physically dilating arteries that have been narrowed or fully closed by plaque a condition termed stenosis or occlusion.

• The Treatment of Peripheral Blood Vessels Damaged: This application mainly involves the use of Bioabsorbable Stents to offer structural assistance to vessels that have been damaged usually due to balloon angioplasty procedure so that they do not crumble at once (recoil) or dissect.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities, and challenges, stating the market conditions.          

Driving Factors

Growing CVD and Aging Population to Boost the Market

Growing CVD and Aging Population is a major factor in the Bioabsorbable Stents Market Growth. The growing prevalence of Cardiovascular Diseases (CVDs) in the world and specifically Coronary Artery Disease (CAD) is a background force behind the Bioabsorbable Stents Market. This tendency is increased by the fact that the population of geriatric patients in the world is growing quicker; advanced age is one of the main risk factors that lead to the need of vascular disease treatment. As a result, the increasing amount of Percutaneous Coronary Intervention (PCI) cases across the globe leaves an ever-increasing patient population that requires arterial support. Such demographic and epidemiological change is a guarantee of high and constant demand on the development of new treatment methods, so it is a critical determinant of the increased use and commercial success of Bioabsorbable Stents around the world.

"Leave-Nothing-Behind" Philosophy to Expand the Market        

The philosophy of the Leave-Nothing-Behind is an influential stimulus that leads to the growth of the Bioabsorbable Stents Market by mitigating a major constrain of permanent metallic devices. This principle underlines the special clinical benefit in which the scaffold only offers the needed temporary support after which it fully dissolves and then the treated vessel naturally returns to its original flexibility and functionality (vaso-motility). This philosophy, by removing the risk of permanent implants due to chronic inflammation, catch-up growth and incredibly late thrombosis of permanent implants, will greatly increase patient and physician confidence and drive market adoption.

Restraining Factor

Higher Initial Cost Impedes Market Growth

The fact that Bioabsorbable Stents have a Higher Initial Cost gives them a big hindrance to grow quickly and extensively in the market and particularly when other well- known and cheaper alternative to Bioabsorbable Stents with metallic stents in the form of drug-eluting stents (DES). The difficulty of materials science, production, and the lengthy amount of research and development that must go into these higher-level biodegradable devices directly translate into the high price point. This price difference usually puts a strain on healthcare budgets, and restricts their use with price-sensitive emerging economies, or in hospitals with tight budgets, and compels many institutions to switch to the more cost-effective, although clinically equivalent, permanent metallic stents, thereby inhibiting the general growth of the bioabsorbable market share.

• Download Free Sample to learn more about this report

•  

BIOABSORBABLE STENTS MARKET REGIONAL INSIGHTS

• North America

The Bioabsorbable Stents Market is now controlled by North America, which leads the market mainly due to the high level of development of the healthcare infrastructure of the region, high level of expenditure on the healthcare sector of the population and the rapid introduction of new medical technologies. The United States Bioabsorbable Stents Market is the most influential country market segment, as it is characterized by large number of coronary and peripheral intervention cases, high prevalence of cardiovascular diseases, and a good reimbursement regulatory policy on advanced cardiovascular device usage, although the product is relatively expensive.

• Europe

The second-largest regional bioabsorbable stented market is Europe, which has a high level of research and development and a highly advanced regulatory framework that in most cases helps in the first clinical trials and approvals of new gadget. The market expansion can be maintained through raising the awareness of clinicians about the long-term usefulness of the leave-nothing-behind principle, with Germany and France serving as the major sources of revenues and clinical integration on the continent.

• Asia

The Asia Pacific region is estimated to be the fastest expanding market in the world, which has enormous opportunities due to the population being aging fast, disposable income growing, and the healthcare infrastructure in the countries such as China, India, and Japan is being modernized. The increased rates of cardiovascular and lifestyle diseases, combined with the increasing access to sophisticated medical procedures and an escalating increase in the need of less invasive medical operations pose APAC with considerable growth in the utilization of Bioabsorbable Stents.

KEY INDUSTRY PLAYERS

Key Players Transforming the Bioabsorbable Stents Market Landscape through Innovation and Global Strategy

Through the innovation of strategies and market development, the market players in the field of enterprise are shaping the Bioabsorbable Stents Market. Certain of these can be seen as advancements in designs, Products of materials, and controls, besides the use of smarter technologies for the enhancement of functionality and operational flexibility. Managers are aware of their responsibility to spend money on the development of new products and processes and expand the scope of manufacturing. This market expansion also assists in diversifying the market growth prospects and attaining higher market demand for the product in numerous industries.

List of Top Management Companies          

• Abbott Vascular (U.S)
• Boston Scientific (U.S)
• Kyoto Medical Planning Co., Ltd (Japan)
• Elixir (Singapore)
• Arterial Remodeling Technologies (France)

KEY INDUSTRY DEVELOPMENT

March 2024: Boston Scientific has made strategic growth and innovation in its next generation across its cardiovascular no less than 2024. The company has greatly enhanced its vascular stroke-prevention segment by acquiring Silk Road Medical and its Transcarotid Artery Revascularization (TCAR) platform. Moreover, in early 2024, Boston Scientific was granted an essential FDA approval of its Agent drug-coated balloon catheter that presents a valuable non-stent option to address the problem of coronary in-stent restenosis (ISR). To show their interest in electrophysiology, the company also keeps on improving its Farapulse PFA ablation system with the introduction of advanced mapping and catheter products such as the Farawave NAV and OPAL HDx system.

REPORT COVERAGE

This report is based on historical analysis and forecast calculations that aim to provide readers with a comprehensive understanding of the global Bioabsorbable Stents Market from multiple angles, thereby offering sufficient support for readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the market's growth by discovering the dynamic categories and potential areas of innovation whose application may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points for consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies, and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.